Brain Cancer Trial, Recruiting NCT04233788 Sponsor: Insel Gruppe AG, University Hospital Bern Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT04233788
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Healthy people who are able to lie still inside an MRI scanner for up to one hour
  • People who have been told they may have a growth or mass in their brain that needs further investigation
  • People who are willing and able to give written consent to take part

Who may not be able to join:

  • Anyone under 18 years of age
  • Anyone who is not able to make their own decision about taking part due to a mental health condition or cognitive difficulty
  • Women who are pregnant
  • People who have previously been diagnosed with cancer or a degenerative brain or nervous system condition
  • People who have an active implanted medical device, such as a pacemaker or nerve stimulator
  • People who are being treated as an emergency patient
  • People who have tattoos on their head or neck area

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Johannes Slotboom, PhD, University of Bern

Phone: +41316327469

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Insel Gruppe AG, University Hospital Bern
Registry
ClinicalTrials.gov
Start date
1 September 2021
Est. completion
31 December 2024

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Optimal MR-sequence for IDH-typing

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov